India - English - Central Drugs Standard Control Organization

gsk - dithranol,salicylic acid,coaltar,hydrocortisone - hc oint - 1.15%,1.15%,5.3,0.5;%w/w - 3g

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 12.5 mg - suppository, moulded - excipient ingredients: hydrogenated coco-glycerides; hard fat - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. short term (up to three days) treatment of post-operative pain in children.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac potassium, quantity: 50 mg - tablet, sugar coated - excipient ingredients: colloidal anhydrous silica; calcium phosphate; magnesium stearate; maize starch; povidone; sodium starch glycollate; microcrystalline cellulose; iron oxide red; macrogol 8000; sucrose; purified talc; titanium dioxide - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 100 mg - suppository, moulded - excipient ingredients: - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. short term (up to three days) treatment of post-operative pain in children.

Ireland - English - HPRA (Health Products Regulatory Authority)

organon pharma (ireland) limited - betamethasone dipropionate; salicylic acid - cutaneous solution - 0.05 %w/w+2 percent weight/weight - corticosteroids, potent, other combinations; betamethasone

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hoe pharmaceuticals sdn. bhd. - betamethasone dipropionate; salicylic acid/2-hydroxybenzoic acid -

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - mometasone furoate; salicylic acid - ointment - 1 mg/g - mometasone furoate 1 mg/g; salicylic acid 50 mg/g

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

organon pharma (uk) ltd - betamethasone dipropionate; salicylic acid - cutaneous ointment - 500microgram/1gram ; 30mg/1gram

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

noripharma sdn. bhd. - betamethasone dipropionate (micronised); salicylic acid -

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 25mg;  ;   - enteric coated tablet - 25 mg - active: diclofenac sodium 25mg     excipient: ammonia solution colloidal silicon dioxide hypromellose   silicone antifoam emulsion (enteric-coat)   pigment suspension white   pigment suspension white (colour-coat) lactose monohydrate macrogol 8000 magnesium stearate maize starch methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil   povidone purified talc     purified water     sodium starch glycolate - treatment of: inflammatory and degenerative forms of rheumatism - rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism; acute attacks of gout; post-traumatic and postoperative pain, inflammation, and swelling, e.g. following dental or orthopaedic surgery; painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis; as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. fever alone is not an indication.